AM6545 is a selective and potent peripheral restricted cannabinoid receptor 1 (CB1) antagonist that inhibits the CB2 receptor, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate-induced obese mice, and may be useful in the study of obesity and diabetes.
Molekulargewicht:
556.46
Reinheit:
97.03%
CAS Nummer:
[1245626-05-4]
Formel:
C26H23Cl2N5O3S
Target-Kategorie:
Cannabinoid Receptor
T22563
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten